In a mouse model where IGF2BP2 was instead upregulated in the liver by the transgene, lipid storage was enhanced, which led to fibrosis and NAFLD [40,41,42]. Here, IGF2BP2 is linked to metabolic dysfunction-associated steatotic liver disease.